Professor Zhengming Chen
Research groups
Websites
-
China Oxford Centre for International Health Research
Co-Executive Director
Zhengming Chen
DPhil
Professor of Epidemiology and Director of China Programmes
- MRC PHRU Programme Leader
- Clinical Trial Service Unit and Epidemiological Studies Unit
Professor Zhengming Chen qualified in medicine at Shanghai Medical University in 1983 (now Fudan University), and gained his DPhil in Epidemiology at the University of Oxford in 1993. He was appointed as Professor of Epidemiology by the University of Oxford in 2006. He is now the Director of the China Programs at the Oxford University’s Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) and co-executive director of the China Oxford Centre for International Health Research. His main researches focus on the environmental and genetic causes of chronic disease, evidence-based medicine and evaluation of widely practicable treatments for chronic diseases (such as IHD, stroke and cancer) as well as efficient strategies for chronic disease control in developing countries. Over the past 20 years, he has led several large randomised trials in heart disease (eg, COMMIT/CCS-2), stroke (eg, CAST) and cancer and 3 cohort studies involving >750,000 individuals. Since 2003 he has been the lead principal investigator in the UK for the China Kadoorie Biobank (CKB) prospective study of 0.5 million adults. He leads a research team in Oxford which is responsible for study design and development of procedures and IT systems for the CKB, and for central data management, curation and detailed analyses. He is an honorary professor of Peking Union Medical College and Fudan University in China.
Recent publications
-
Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study.
Journal article
Kartsonaki C. et al, (2024), Int J Cancer, 154, 1423 - 1432
-
Proteomic analyses in diverse populations improved risk prediction and identified new drug targets for type 2 diabetes
Journal article
YAO P. et al, (2024), Diabetes Care
-
Association between health insurance cost-sharing and choice of hospital tier for cardiovascular diseases in China: a prospective cohort study.
Journal article
Levy M. et al, (2024), Lancet Reg Health West Pac, 45
-
Using routinely collected data to determine care cascades of hypertension and type-2 diabetes management in China: a cross-sectional study.
Journal article
Xiong S. et al, (2024), Lancet Reg Health West Pac, 45
-
Reproductive factors and risk of lung cancer among 300,000 Chinese female never-smokers: evidence from the China Kadoorie Biobank study.
Journal article
Elbasheer MMA. et al, (2024), BMC Cancer, 24